Paediatric Healthcare Market by Treatment, Indication, End-User

Description

List of Tables

[192 Pages Report] The Paediatric Healthcare Market size was estimated at USD 107.01 billion in 2023 and expected to reach USD 114.55 billion in 2024, at a CAGR 7.53% to reach USD 177.94 billion by 2030.

Pediatric healthcare is a branch of medicine pertaining to the provision of medical care to infants, children, and adolescents. The age range typically considered for pediatric care is from birth up to 18 years. This field of healthcare encompasses a wide range of services, including prophylactic health care for healthy children and medical care for those who are acutely and chronically ill. Growing awareness among child parents of the need for adequate treatment, supported by rising government support and initiatives to promote pediatric health, has significantly contributed to the growth of the market. In addition, increasing investments in research & development for pediatric-specific medical devices and pharmaceuticals have a positive impact on market expansion. Despite the growth, the market faces several challenges, including high costs associated with pediatric care and specialty drugs, a shortfall in pediatric healthcare professionals, and uneven access to healthcare services across different regions. Regulatory hurdles for the approval of pediatric pharmaceuticals and devices also constitute significant limitations, as does the complexity of managing diverse health issues in a pediatric population. Technological advancements in neonatal and pediatric care equipment create lucrative opportunities for market growth. Additionally, the market sees potential in expanding access through telehealth services tailored for children and in integrating AI and machine learning to improve pediatric diagnostic and treatment protocols.

KEY MARKET STATISTICS
Base Year [2023]	USD 107.01 billion
Estimated Year [2024]	USD 114.55 billion
Forecast Year [2030]	USD 177.94 billion
CAGR (%)	7.53%

Treatment: Expanding usage of pediatric healthcare for immunotherapy for a myriad of health conditions

Immunotherapy represents a promising frontier in pediatric healthcare, offering targeted treatments that harness and modulate the immune system to fight diseases, particularly cancer and chronic autoimmune disorders. In the pediatric population, immunotherapy includes treatments such as monoclonal antibodies, vaccine therapy, and immune checkpoint inhibitors, which have been adapted for use in children with various malignancies and immune system dysfunctions. Medications for pediatric patients are a cornerstone of treatment for a myriad of health conditions. These medications must be carefully dosed according to the child's age, weight, and health status to minimize side effects and ensure efficacy. Drug formulations for children are often distinct from adult formulations, sometimes requiring liquid suspensions, chewable tablets, or dissolvable strips to facilitate administration. Surgeries in pediatric healthcare cater to a range of complex conditions that might be congenital or acquired. Pediatric surgeons are trained to operate on infants, children, and adolescents, ensuring that procedures are adapted to the physiological characteristics of younger patients. Common surgeries include procedures for congenital heart defects, removal of tumors, organ transplants, and corrective surgeries for orthopedic anomalies.

Indication: Growing need for effective, age-appropriate medications in pediatric healthcare to manage asthma & allergies

Asthma & allergies are common chronic conditions afflicting children. The market for pediatric asthma and allergy products is driven by the need for effective, age-appropriate medications and devices. Treatments include inhalers, nebulizers, antihistamines, and immunotherapies targeted to children's needs and physiological differences compared to adults. Cardiac disorders in the pediatric population, though less common, require specialized care and treatment options. This market segment prioritizes the availability of congenital heart defect repair devices, pediatric ventricular assist devices, and age-specific cardiac medications. Genetic disorders in children, such as cystic fibrosis, Duchenne muscular dystrophy, and rare chromosomal anomalies, have bespoke therapeutic needs. Treatment approaches include gene therapy, enzyme replacement therapies, and disease-modifying treatments. Metabolic disorders in children, such as Type 1 diabetes and inborn errors of metabolism, require continuous monitoring and lifelong management.

End-User: Growing usage of pediatric healthcare across hospitals & clinics that offer a wide range of services

Ambulatory care centers are healthcare facilities where patients receive outpatient services, including diagnosis, observation, treatment, and rehabilitation services that do not require an overnight hospital stay. For pediatric patients, these centers are particularly appealing due to their convenience, reduced cost, and less intimidating environment compared with hospitals. Homecare settings involve healthcare services provided in a patient's home. Pediatric homecare can be critical for families with children who have chronic conditions or special needs or are recovering from surgery or lengthy hospital stays. Hospitals & clinics represent one of the largest segments of pediatric healthcare providers. They offer a wide range of services from general pediatric care to specialized treatments and surgeries.

Regional Insights

In the American region, pediatric healthcare is characterized by a combination of private and public funding, with an emphasis on innovation in treatment and drug development. Consumer needs are heavily influenced by the availability of advanced healthcare infrastructure and a strong focus on preventive care. Customer purchasing behavior leans towards providers that offer comprehensive services and holistic care. Investments in pediatric research are significant, with initiatives often funded through public-private partnerships. The European Union presents a diverse healthcare landscape with varying levels of access and quality. The common trend towards equitable healthcare systems is built on universal coverage. Consumer needs in pediatric healthcare focus on integrative services that address both the physiological and psychological aspects of child development. Emerging research within EU countries often explores the efficacy of pediatric treatments and health system improvements. The European Commission supports several research initiatives and collaborations aimed at enhancing pediatric healthcare. The APAC market is rapidly growing, with government policies favoring expanded coverage and improved healthcare access for children. Countries including China, India, and Japan are seeing significant research investment, particularly in the development of pediatric drugs and vaccines.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Paediatric Healthcare Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Paediatric Healthcare Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Paediatric Healthcare Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AstraZeneca PLC, Aveanna Healthcare, LLC., Becton, Dickinson and Company, bioMerieux SA, Boehringer Ingelheim International GmbH, Eisai Co., Ltd., Eli Lilly and Company, Enviva Inc., Gilead Sciences, Inc., Glaxosmithkline PLC, GP Pharm, S.A., Henin Lukinz Pvt. Ltd., Interim HealthCare Inc., Janssen Global Services LLC, Johnson & Johnson Services, Inc., Medexus Pharmaceuticals, Inc., Medtronic PLC, Merck KGaA, Novartis AG, Olympus Corporation, ORPHELIA Pharma, Pfizer Inc., Proveca Ltd., Royal Philips, Sanofi S.A, Siemens AG, Strykar Corporation, The Procter & Gamble Company, Thermo Fisher Scientific, Inc., and Viatris Inc..

Market Segmentation & Coverage

This research report categorizes the Paediatric Healthcare Market to forecast the revenues and analyze trends in each of the following sub-markets:

Treatment
- Immunotherapy
- Medications
- Surgeries

Indication
- Asthma & Allergies
- Cardiac Disorders
- Genetic Disorders
- Metabolic Disorders

End-User
- Ambulatory Care Centers
- Homecare Settings
- Hospitals & Clinics

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Paediatric Healthcare Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Paediatric Healthcare Market?

3. What are the technology trends and regulatory frameworks in the Paediatric Healthcare Market?

4. What is the market share of the leading vendors in the Paediatric Healthcare Market?

5. Which modes and strategic moves are suitable for entering the Paediatric Healthcare Market?

Product Code: MRR-434CCDA04E27

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing number of deaths attributed to viral infections and malnutrition
  - 5.1.1.2. Rising government support and initiatives to promote pediatric health
  - 5.1.1.3. Growing awareness among child parents for adequate treatment
- 5.1.2. Restraints
  - 5.1.2.1. Ethical concerns and small size of the study population
- 5.1.3. Opportunities
  - 5.1.3.1. Growing research and development in technological advancements
  - 5.1.3.2. Surge in medical expenditure in emerging economies
- 5.1.4. Challenges
  - 5.1.4.1. Lack of pediatricians across the globe
5.2. Market Segmentation Analysis
- 5.2.1. Treatment: Expanding usage of pediatric healthcare for immunotherapy for a myriad of health conditions
- 5.2.2. Indication: Growing need for effective, age-appropriate medications in pediatric healthcare to manage asthma & allergies
- 5.2.3. End-User: Growing usage of pediatric healthcare across hospitals & clinics that offer a wide range of services
5.3. Market Disruption Analysis
5.4. Porter's Five Forces Analysis
- 5.4.1. Threat of New Entrants
- 5.4.2. Threat of Substitutes
- 5.4.3. Bargaining Power of Customers
- 5.4.4. Bargaining Power of Suppliers
- 5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis

6. Paediatric Healthcare Market, by Treatment

6.1. Introduction
6.2. Immunotherapy
6.3. Medications
6.4. Surgeries

7. Paediatric Healthcare Market, by Indication

7.1. Introduction
7.2. Asthma & Allergies
7.3. Cardiac Disorders
7.4. Genetic Disorders
7.5. Metabolic Disorders

8. Paediatric Healthcare Market, by End-User

8.1. Introduction
8.2. Ambulatory Care Centers
8.3. Homecare Settings
8.4. Hospitals & Clinics

9. Americas Paediatric Healthcare Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Paediatric Healthcare Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Paediatric Healthcare Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
- 12.3.1. Cortica Closes USD 75 Million in New Funding Round and Acquires Springtide Child Development
- 12.3.2. Pediatric Behavioral Health Provider Bend Health Moves Out of Stealth Mode with USD 32M in Funding
- 12.3.3. Ipsen to Acquire Albireo Accelerating Growth in Rare Disease with Treatments for Several Pediatric Liver Diseases
12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

13.1. Key Company Profiles
13.2. Key Product Portfolio